Nafcillin
Nafcillin for Injection, USP
Approved
Approval ID
4d3b0076-3780-413f-9052-b23be5f18f01
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 14, 2023
Manufacturers
FDA
WG Critical Care, LLC
DUNS: 829274633
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nafcillin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-221
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 15, 2021
FDA Product Classification
INGREDIENTS (2)
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM
NAFCILLIN SODIUMActive
Quantity: 1 g in 1 1
Code: 49G3001BCK
Classification: ACTIM
Nafcillin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-222
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 15, 2021
FDA Product Classification
INGREDIENTS (2)
NAFCILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: 49G3001BCK
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM